SFI
RGNX icon

Susquehanna Fundamental Investments’s Regenxbio RGNX Stock Holding History

Susquehanna Fundamental Investments’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-103,065
Closed -$2.17M – 999
2024
Q1 		$2.17M Buy
+103,065
New +$1.83M 0.1% 218
2020
Q4 		– Sell
-9,700
Closed -$267K – 1588
2020
Q3 		$267K Buy
+9,700
New +$316K 0.01% 1102

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Susquehanna Fundamental Investments's RGNX Position: Q2 2024 in Review

Susquehanna Fundamental Investments sold out of Regenxbio (RGNX) in Q2 2024, closing a stake of 103,065 shares — an estimated $2.17M sold.

Susquehanna Fundamental Investments first reported a position in RGNX in Q3 2020 and held it in 2 quarters. The position peaked at $2.17M in Q1 2024. 181 funds tracked by Wall St. Rank hold RGNX as of Q2 2024.

  • Susquehanna Fundamental Investments reported no remaining Regenxbio position as of Q2 2024 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 103,065 Regenxbio shares in Q2 2024, an estimated $2.17M.
  • Susquehanna Fundamental Investments first reported a position in Regenxbio in Q3 2020 and held it in 2 quarters.
  • Susquehanna Fundamental Investments's Regenxbio position peaked at $2.17M in Q1 2024.
  • 181 funds tracked by Wall St. Rank held Regenxbio as of Q2 2024.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2024, filed 15 Aug 2024.